MercadoLibre launches deliveries within an hour, expands pharmacy business in Brazil

By Reuters News

SAO PAULO, Sept 24 (Reuters) - MercadoLibre MELI.O launched product deliveries within an hour in Brazil, starting in the city of Sao Paulo, Fernando Yunes, the firm's executive vice president of commerce, said on Thursday.

The Latin American e-commerce and fintech company also will expand its pharmacy business in the country, with its own pharmacy in Sao Paulo beginning to sell prescription products this month, Yunes said at a company event.

  • MercadoLibre will add third-party pharmacies to its e-commerce platform in Brazil as of October, kicking off in Sao Paulo with three drugstore chains, which were not named.

  • The company expects to have 20 third-party physical drugstore locations in Sao Paulo on its platform by the end of the year.

  • The one-hour service, which started as a test in an undisclosed region of Sao Paulo and is expected to be expanded, will include products such as medications, food and others.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.